SAB Therapeutics (NASDAQ: SABS) shares are trading higher on Thursday after the company said it has been granted Fast Track designation from the FDA for SAB-176 influenza immunotherapy with high cross-reactivity to multiple strains of influenza.
Panbela Therapeutics (NASDAQ: PBLA) shares are trading higher on Wednesday after the company announced the first patient has been enrolled in the Phase II trial of CPP-1X-T.
Creative Medical Technology (NASDAQ: CELZ) shares are trading higher on Wednesday after the company announced one-year follow-up data and significant efficacy using CELZ-001 to treat patients with Type 2 Diabetes without any serious adverse effects reported.
ZeroFox (NASDAQ: ZFOX) shares are trading higher on Tuesday after the company announced it partnered with Google Cloud to disrupt phishing attacks and malicious URLs.
Moderna (NASDAQ: MRNA) shares are trading lower on Tuesday after the company said its first influenza candidate, mRNA-1010, did not accrue sufficient cases at the interim efficacy analysis to declare early success in the Phase 3 Northern Hemisphere efficacy trial and the independent DSMB recommended continu
Airbnb (NASDAQ: ABNB) shares are trading lower amid overall market weakness on concerns of a softening economy following greater-than-expected jobless claims. Also, a bearish report from Bear Cave could be negatively impacting the stock as well.